Mark Pruzanski Insider Profile
4 Followers
Mark Pruzanski, Director at Equillium, holds ― shares in Equillium (Ticker: EQ), holds 618.89K shares in Intercept Pharma (Ticker: ICPT).
Mark Pruzanski's Trading History
| ICPTIntercept Pharma | Dec 02, 2021 | ― | Uninformative Buy | 105.63K | $11.76M | |
| EQEquillium | ― | Director | ― | ― |
You May Also Like
Mark Pruzanski insider profile FAQ
What is the percentage of profitable transactions made by Mark Pruzanski?
The percentage of profitable transactions made by Mark Pruzanski is 67%.
What is the average return per transaction made by Mark Pruzanski?
The average return per transaction made by Mark Pruzanski is 13.10%.
What stocks does Mark Pruzanski hold?
Mark Pruzanski holds: EQ, ICPT stocks.
What was Mark Pruzanski's most profitable transaction?
Mark Pruzanski’s most profitable transaction was an Informative Buy of ICPT stock on April 9, 2018. The return on the trade was 70.90%.
What is Mark Pruzanski's role in Equillium?
Mark Pruzanski's role in Equillium is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
